140 related articles for article (PubMed ID: 1390332)
1. Long-term hemodynamic effects of nifedipine on congenital heart disease with Eisenmenger's mechanism in children.
Wimmer M; Schlemmer M
Cardiovasc Drugs Ther; 1992 Apr; 6(2):183-6. PubMed ID: 1390332
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies of hemodynamics under prostacyclin and nifedipine in patients with Eisenmenger syndrome].
Gildein HP; Wildberg A; Mocellin R
Z Kardiol; 1995 Jan; 84(1):55-63. PubMed ID: 7863716
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease.
Engelfriet PM; Duffels MG; Möller T; Boersma E; Tijssen JG; Thaulow E; Gatzoulis MA; Mulder BJ
Heart; 2007 Jun; 93(6):682-7. PubMed ID: 17164490
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.
Garg N; Tripathy N; Sinha N
Cardiol Young; 2011 Dec; 21(6):631-8. PubMed ID: 21729508
[TBL] [Abstract][Full Text] [Related]
5. The use of nifedipine in patients with Eisenmenger's syndrome complicating patency of the arterial duct.
Wong CK; Lau CP; Leung WH; Cheng CH
Int J Cardiol; 1989 Nov; 25(2):173-8. PubMed ID: 2807605
[TBL] [Abstract][Full Text] [Related]
6. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.
Galie N; Manes A; Palazzini M; Negro L; Marinelli A; Gambetti S; Mariucci E; Donti A; Branzi A; Picchio FM
Drugs; 2008; 68(8):1049-66. PubMed ID: 18484798
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary hypertension in children with Down's syndrome and congenital heart disease. Is it really more severe?].
Vázquez-Antona CA; Lomelí C; Buendía A; Vargas-Barrón J
Arch Cardiol Mex; 2006; 76(1):16-27. PubMed ID: 16749498
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of nifedipine and oxygen in children with pulmonary hypertension.
Wimmer M; Schlemmer M; Ebner F
Cardiovasc Drugs Ther; 1988 Dec; 2(5):661-8. PubMed ID: 3154641
[TBL] [Abstract][Full Text] [Related]
9. Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects.
Li Q; Dimopoulos K; Zhang C; Zhu Y; Liu Q; Gu H
Pediatr Cardiol; 2018 Apr; 39(4):757-762. PubMed ID: 29426959
[TBL] [Abstract][Full Text] [Related]
10. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
Berger RM; Beghetti M; Galiè N; Gatzoulis MA; Granton J; Lauer A; Chiossi E; Landzberg M
Int J Cardiol; 2010 Oct; 144(3):373-8. PubMed ID: 19464064
[TBL] [Abstract][Full Text] [Related]
11. Acute haemodynamic effects of nifedipine in patients with ventricular septal defect.
Berisha S; Goda A; Kastrati A; Frasheri A; Popa Y
Br Heart J; 1988 Aug; 60(2):149-55. PubMed ID: 3415874
[TBL] [Abstract][Full Text] [Related]
12. The early and late effects of surgical closure of ventricular septal defects on pulmonary vascular dynamics.
Kawashima Y; Mori M
Jpn Circ J; 1976 Jun; 40(6):637-43. PubMed ID: 950731
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic studies of nifedipine (Adalat) in pulmonary hypertension in childhood].
Wimmer M; Schlemmer M; Ebner F
Wien Klin Wochenschr; 1986 Nov; 98(21):740-3. PubMed ID: 3101292
[TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
Brownlee JR; Beekman RH; Rosenthal A
Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
[TBL] [Abstract][Full Text] [Related]
15. [Lactobacillus paracasei endocarditis in an 18-yeard-old patient with trisomy 21, atrioventricular septal defect and Eisenmenger complex: therapeutic problems].
Schmidt V; Wolter M; Lenschow U; Kienast W
Klin Padiatr; 2001; 213(1):35-8. PubMed ID: 11225474
[TBL] [Abstract][Full Text] [Related]
16. Study of hemodynamic changes with oxygen inhalation in VSD associated with pulmonary hypertension.
Teramoto S; Fujiwara T; Takahara I
Jpn Circ J; 1976 Jun; 40(6):623-7. PubMed ID: 950728
[TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide in congenital heart disease.
Roberts JD; Lang P; Bigatello LM; Vlahakes GJ; Zapol WM
Circulation; 1993 Feb; 87(2):447-53. PubMed ID: 8425292
[TBL] [Abstract][Full Text] [Related]
18. Congenital heart disease in Down's syndrome.
Laursen HB
Br Heart J; 1976 Jan; 38(1):32-8. PubMed ID: 1252293
[TBL] [Abstract][Full Text] [Related]
19. Down's syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease.
Clapp S; Perry BL; Farooki ZQ; Jackson WL; Karpawich PP; Hakimi M; Arciniegas E; Green EW; Pinsky WW
J Thorac Cardiovasc Surg; 1990 Jul; 100(1):115-21. PubMed ID: 2142250
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of Rho-kinase inhibitor fasudil on pulmonary arterial hypertension in patients with congenital heart defects.
Xiao JW; Zhu XY; Wang QG; Zhang DZ; Cui CS; Zhang P; Chen HY; Meng LL
Circ J; 2015; 79(6):1342-8. PubMed ID: 25797071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
